An update on gastric cancer.

[1]  G. Petris.  Gastric adenocarcinoma and proximal polyposis of the stomach , 2020, Definitions.

[2]  Puneet,et al.  Oesophagogastric Surgery , 2018, SBAs and EMIs for the General Surgery FRCS.

[3]  Mário Dinis-Ribeiro,et al.  Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis , 2016, European journal of gastroenterology & hepatology.

[4]  Dong Joon Shin,et al.  Eleven-year experience with 3000 cases of laparoscopic gastric cancer surgery in a single institution: analysis of postoperative morbidities and long-term oncologic outcomes , 2016, Surgical Endoscopy.

[5]  R. Makuuchi,et al.  Late phase II study of robot-assisted gastrectomy with nodal dissection for clinical stage I gastric cancer , 2016, Surgical Endoscopy.

[6]  M. McCarter,et al.  Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  S. Libutti,et al.  The value of FDG‐PET in the staging of gastric adenocarcinoma: A single institution retrospective review , 2016, Journal of surgical oncology.

[8]  S. Maithel,et al.  The importance of surgical margins in gastric cancer , 2016, Journal of surgical oncology.

[9]  S. McGuire.  World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. , 2016, Advances in nutrition.

[10]  P. Gao,et al.  Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis , 2016, World Journal of Surgical Oncology.

[11]  F. Ozdener,et al.  A study of the combination of oxaliplatin, capecitabine, and herceptin (trastuzumab) and chemoradiotherapy in the adjuvant setting in operated patients with HER2+ gastric or gastro-esophageal junction cancer (TOXAG study). , 2016 .

[12]  Taeil Son,et al.  Laparoscopic gastric cancer surgery: Current evidence and future perspectives. , 2016, World journal of gastroenterology.

[13]  Kurt Straif,et al.  Carcinogenicity of consumption of red and processed meat. , 2015, The Lancet. Oncology.

[14]  D. Graham,et al.  Autoimmune gastritis: Pathologist's viewpoint. , 2015, World journal of gastroenterology.

[15]  K. Yao.  Clinical Application of Magnifying Endoscopy with Narrow-Band Imaging in the Stomach , 2015, Clinical endoscopy.

[16]  A. Sonnenberg,et al.  The stomach in health and disease , 2015, Gut.

[17]  Yuhong Yuan,et al.  Extent of lymph node dissection for adenocarcinoma of the stomach. , 2015, The Cochrane database of systematic reviews.

[18]  P. Malfertheiner,et al.  Kyoto global consensus report on Helicobacter pylori gastritis , 2015, Gut.

[19]  F. Roviello,et al.  Multimodal treatment of gastric cancer in the west: Where are we going? , 2015, World journal of gastroenterology.

[20]  G. Spolverato,et al.  Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative , 2015, Annals of Surgical Oncology.

[21]  Yutaka Saito,et al.  Indications and Techniques for Endoscopic Submucosal Dissection , 2015, The American Journal of Gastroenterology.

[22]  R. van Hillegersberg,et al.  Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers , 2015, Journal of Medical Genetics.

[23]  B. Fernandez,et al.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. , 2015, JAMA oncology.

[24]  S. Hohmann,et al.  Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers , 2015, Surgical Endoscopy.

[25]  S. Mocellin,et al.  Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. , 2015, The Cochrane database of systematic reviews.

[26]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[27]  Joon-Oh Park,et al.  Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Yu,et al.  Laparoscopic vs open D2 gastrectomy for locally advanced gastric cancer: a meta-analysis. , 2014, World journal of gastroenterology.

[29]  D. Shin,et al.  Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. , 2014, The Lancet. Oncology.

[30]  H. Ashrafian,et al.  Laparoscopic gastric surgery for cancer: where do we stand? , 2014, World journal of gastroenterology.

[31]  Sang-Yong Son,et al.  Minimally invasive surgery in gastric cancer. , 2014, World journal of gastroenterology.

[32]  Y. Yamashita,et al.  Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. , 2014, World journal of gastroenterology.

[33]  Naotoshi Sugimoto,et al.  Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. , 2014, The Lancet. Oncology.

[34]  C. Caldas,et al.  Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. , 2014, Gastrointestinal endoscopy.

[35]  B. Xiong,et al.  An Updated Meta-Analysis of Randomized Controlled Trial Assessing the Effect of Neoadjuvant Chemotherapy in Advanced Gastric Cancer , 2014, Cancer investigation.

[36]  L. Lorenzon,et al.  Lymph-Node Ratio Classification Strongly Correlates with Cancer Survivals of Patients Who Underwent R0 Resection for Gastric Cancer with More than 15 Nodes Harvested , 2014, European Surgical Research.

[37]  F. Qi,et al.  Pylorus-Preserving versus Distal Subtotal Gastrectomy for Surgical Treatment of Early Gastric Cancer: A Meta-Analysis. , 2014, Hepato-gastroenterology.

[38]  H. Liang,et al.  Clinical significance of lymph node metastasis in gastric cancer. , 2014, World journal of gastroenterology.

[39]  K. Song,et al.  Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Villanueva.  Gastric cancer: A master KLASS in laparoscopic gastrectomy , 2014, Nature Reviews Clinical Oncology.

[41]  Mithat Gonen,et al.  Stage-Stratified Prognosis of Signet Ring Cell Histology in Patients Undergoing Curative Resection for Gastric Adenocarcinoma , 2014, Annals of Surgical Oncology.

[42]  C. Fuchs,et al.  Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial , 2014, The Lancet.

[43]  M. Morino,et al.  Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer , 2014, The British journal of surgery.

[44]  C. Earle,et al.  Optimal Management of Gastric Cancer: Results From an International RAND/UCLA Expert Panel , 2014, Annals of surgery.

[45]  Q. Nunes,et al.  Comparison of short-term clinical outcomes between robotic and laparoscopic gastrectomy for gastric cancer: a meta-analysis of 2495 patients. , 2013, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[46]  Rong Li,et al.  Robotic versus Open Gastrectomy for Gastric Cancer: A Meta-Analysis , 2013, PloS one.

[47]  Yoon Young Choi,et al.  Laparoscopic gastrectomy for advanced gastric cancer: Are the long‐term results comparable with conventional open gastrectomy? A systematic review and meta‐analysis , 2013, Journal of surgical oncology.

[48]  Wei Huang,et al.  Laparoscopic vs open total gastrectomy for gastric cancer: a meta-analysis. , 2013, World journal of gastroenterology.

[49]  C. Vieira,et al.  Performance of Glutamate Dehydrogenase and Triose Phosphate Isomerase Genes in the Analysis of Genotypic Variability of Isolates of Giardia duodenalis from Livestocks , 2013, BioMed research international.

[50]  M. Rugge,et al.  Autoimmune atrophic gastritis—pathogenesis, pathology and management , 2013, Nature Reviews Gastroenterology &Hepatology.

[51]  P. Hall,et al.  Clinical Investigation : Gynecologic Cancer Radiation Dose and Subsequent Risk for Stomach Cancer in Long-term Survivors of Cervical Cancer , 2013 .

[52]  Q. Guan,et al.  Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: A meta‐analysis , 2013, Journal of surgical oncology.

[53]  P. Hall,et al.  Increased stomach cancer risk following radiotherapy for testicular cancer , 2014, British Journal of Cancer.

[54]  P. Yu,et al.  Laparoscopy-Assisted vs. Open Total Gastrectomy for Advanced Gastric Cancer: Long-Term Outcomes and Technical Aspects of a Case–Control Study , 2013, Journal of Gastrointestinal Surgery.

[55]  F. Roviello,et al.  Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study. , 2013, JAMA surgery.

[56]  M. Gonen,et al.  Association of Positive Transection Margins with Gastric Cancer Survival and Local Recurrence , 2013, Annals of Surgical Oncology.

[57]  Yulong He,et al.  Extended multi-organ resection for cT4 gastric carcinoma: A retrospective analysis , 2013, Pakistan journal of medical sciences.

[58]  Sam S. Yoon,et al.  D1 versus D2 lymphadenectomy for gastric cancer , 2013, Journal of surgical oncology.

[59]  Raquel Seruca,et al.  Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  T. Nevalainen.  Pekka Laurén and histological classification of gastric carcinoma , 2013, Gut.

[61]  Ichiro Oda,et al.  Complications of Gastric Endoscopic Submucosal Dissection , 2013, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[62]  G. Hanna,et al.  Long-Term Survival After Gastrectomy for Cancer in Randomized, Controlled Oncological Trials: Comparison between West and East , 2013, Annals of Surgical Oncology.

[63]  F. Roviello,et al.  History, Pathogenesis, and Management of Familial Gastric Cancer: Original Study of John XXIII's Family , 2012, BioMed research international.

[64]  F. Clavel-Chapelon,et al.  Fruit and vegetable intake and the risk of gastric adenocarcinoma: A reanalysis of the european prospective investigation into cancer and nutrition (EPIC‐EURGAST) study after a longer follow‐up , 2012, International journal of cancer.

[65]  A. Meloni-Ehrig,et al.  Gastric cancer: Classification, histology and application of molecular pathology. , 2012, Journal of gastrointestinal oncology.

[66]  H. Yoshiyama,et al.  Epstein-Barr Virus (EBV)-associated Gastric Carcinoma , 2012, Viruses.

[67]  A. Davey,et al.  Prognostic significance of signet ring gastric cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  M. Kaise,et al.  [Endoscopic resection of early gastric cancer]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.

[69]  J. Lagergren,et al.  Gastric stump cancer after distal gastrectomy for benign gastric ulcer in a population‐based study , 2012, International journal of cancer.

[70]  L. Helyer,et al.  Multivisceral resection for gastric cancer: a systematic review , 2012, Gastric Cancer.

[71]  L. Helyer,et al.  A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer , 2012, Gastric Cancer.

[72]  Yukiko Shimizu,et al.  Studies of the Mortality of Atomic Bomb Survivors.Report 12, Part I. Cancer: 1950–1990 , 2012, Radiation research.

[73]  S. Moss.  Faculty of 1000 evaluation for The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. , 2012 .

[74]  T. Kwok,et al.  Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis , 2012, Front. Cell. Inf. Microbio..

[75]  J. Ajani,et al.  Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  D. Ichikawa,et al.  Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy. , 2012, World journal of gastroenterology.

[77]  T. Chen,et al.  The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention , 2012, Gut.

[78]  Masahiro Ito,et al.  Risk Factors for Esophagojejunal Anastomotic Leakage After Elective Gastrectomy for Gastric Cancer , 2012, Journal of Gastrointestinal Surgery.

[79]  Sang-Hoon Ahn,et al.  Laparoscopic Total Gastrectomy with D2 Lymphadenectomy for Advanced Gastric Cancer , 2012, World Journal of Surgery.

[80]  Yukiko Shimizu,et al.  Studies of the Mortality of Atomic Bomb Survivors, Report 14, 1950–2003: An Overview of Cancer and Noncancer Diseases , 2012, Radiation research.

[81]  Y. Bang,et al.  Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial , 2012, The Lancet.

[82]  Zhengyan Kan,et al.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.

[83]  Y. Ohashi,et al.  Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  T. Kitazono,et al.  Familial fundic gland polyposis with gastric cancer , 2011, Gut.

[85]  L. Difronzo,et al.  D2 Lymph Node Dissection Improves Staging in Patients with Gastric Adenocarcinoma , 2011, The American surgeon.

[86]  H. Putter,et al.  Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) , 2011, BMC Cancer.

[87]  J. Fraumeni,et al.  Gastric cancer in individuals with Li-Fraumeni syndrome , 2011, Genetics in Medicine.

[88]  Ping Chen,et al.  Billroth I vs. Billroth II vs. Roux-en-Y following distal gastrectomy: a meta-analysis based on 15 studies. , 2011, Hepato-gastroenterology.

[89]  L. Jacks,et al.  Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients , 2011, Indian journal of surgical oncology.

[90]  O. Jeong,et al.  Clinicopathological Features and Surgical Treatment of Gastric Cancer in South Korea: The Results of 2009 Nationwide Survey on Surgically Treated Gastric Cancer Patients , 2011, Journal of gastric cancer.

[91]  M. Piazuelo,et al.  Helicobacter pylori Infection and Gastric Adenocarcinoma. , 2011, US gastroenterology & hepatology review.

[92]  C. Willett,et al.  Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[93]  T. Aiko,et al.  New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points , 2011, Gastric Cancer.

[94]  J. Pignon,et al.  Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[95]  Norio Shiraishi,et al.  Lymph Node Metastasis of Gastric Cancer , 2011, Cancers.

[96]  P. Schlag,et al.  Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  Y. Yamaoka.  Mechanisms of disease: Helicobacter pylori virulence factors , 2010, Nature Reviews Gastroenterology &Hepatology.

[98]  Keith T. Wilson,et al.  Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk , 2010, Clinical Microbiology Reviews.

[99]  D. Gerber,et al.  Paraneoplastic syndromes: an approach to diagnosis and treatment. , 2010, Mayo Clinic proceedings.

[100]  H. Nielsen,et al.  Enforcing centralization for gastric cancer in Denmark. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[101]  Yoon-Koo Kang,et al.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.

[102]  Yasuo Ohashi,et al.  Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer , 2009 .

[103]  H. Putter,et al.  Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. , 2010, The Lancet. Oncology.

[104]  A. Ponti,et al.  Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer , 2010, The British journal of surgery.

[105]  L. Jacks,et al.  Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram , 2010, Annals of surgery.

[106]  B. Jang,et al.  Clinical outcomes for perforations during endoscopic submucosal dissection in patients with gastric lesions , 2010, Surgical Endoscopy.

[107]  D. Huntsman,et al.  Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. , 2010, Human molecular genetics.

[108]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[109]  Hester F. Lingsma,et al.  Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. , 2010, Gastroenterology.

[110]  C. Mariette,et al.  Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation , 2009, Annals of surgery.

[111]  T. Gotoda,et al.  Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer , 2009, Gastric Cancer.

[112]  S. Narod,et al.  Family history and the risk of gastric cancer , 2009, British Journal of Cancer.

[113]  Catherine Bonaïti-Pellié,et al.  2009 version of the Chompret criteria for Li Fraumeni syndrome. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[114]  R. Chetty,et al.  Gastric Hyperplastic Polyps: A Review , 2009, Digestive Diseases and Sciences.

[115]  F. Bazzoli,et al.  Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer? , 2009, Annals of Internal Medicine.

[116]  S. Hamilton-Dutoit,et al.  EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma , 2009, British Journal of Cancer.

[117]  M. Choi,et al.  The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. , 2008, American journal of surgery.

[118]  A. Nashimoto,et al.  D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. , 2008, The New England journal of medicine.

[119]  M. Choi,et al.  Borrmann Type IV: An Independent Prognostic Factor for Survival in Gastric Cancer , 2008, Journal of Gastrointestinal Surgery.

[120]  Hiroyuki Yoshikawa,et al.  Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup , 2008, Journal of gastroenterology and hepatology.

[121]  D. Park,et al.  Clinicopathological Features and Surgical Outcomes of Patients with Remnant Gastric Cancer after a Distal Gastrectomy , 2008, Annals of Surgical Oncology.

[122]  S. Noh,et al.  Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer , 2008, International Journal of Clinical Oncology.

[123]  N. Lunet,et al.  Smoking and gastric cancer: systematic review and meta-analysis of cohort studies , 2008, Cancer Causes & Control.

[124]  Laura K. Bianchi,et al.  Fundic gland polyp dysplasia is common in familial adenomatous polyposis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[125]  T. A. Nagy,et al.  Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. , 2008, Cancer research.

[126]  N. Espat,et al.  Gastric Adenocarcinoma Arising from Fundic Gland Polyps in a Patient with Familial Adenomatous Polyposis Syndrome , 2008, The American surgeon.

[127]  Yasuo Ohashi,et al.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. , 2007, The New England journal of medicine.

[128]  M. Choi,et al.  Predictive Factors for Lymph Node Metastasis in Early Gastric Cancer With Submucosal Invasion: Analysis of a Single Institutional Experience , 2007, Annals of surgery.

[129]  P. Miron,et al.  Germline E-cadherin mutations in familial lobular breast cancer , 2007, Journal of Medical Genetics.

[130]  S. Tsugane,et al.  Diet and the risk of gastric cancer: review of epidemiological evidence , 2007, Gastric Cancer.

[131]  R. Jeffrey,et al.  CDH1 Truncating Mutations in the E-Cadherin Gene: An Indication for Total Gastrectomy to Treat Hereditary Diffuse Gastric Cancer , 2007, Annals of surgery.

[132]  C. Raut,et al.  Factors Influencing the Volume-Outcome Relationship in Gastrectomies: A Population-Based Study , 2007, Annals of Surgical Oncology.

[133]  S. Ito,et al.  Clinicopathological evaluation of biological behavior of submucosal invasive gastric carcinomas: relationship among lymph node metastasis, mucin phenotype and proliferative activity. , 2007, The journal of medical investigation : JMI.

[134]  A. Kiss,et al.  Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer , 2006, Cancer.

[135]  M. Blaser,et al.  Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. , 2006, Journal of the National Cancer Institute.

[136]  S. Larsson,et al.  Fruit and Vegetable Consumption and Incidence of Gastric Cancer: A Prospective Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[137]  F. Roviello,et al.  Number of lymph node metastases and its prognostic significance in early gastric cancer: A multicenter italian study , 2006, Journal of surgical oncology.

[138]  D. Ilson.  Commentary on Roviello et al., JSO‐2005‐00363.R1 , 2006 .

[139]  C. González,et al.  Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. , 2006, World journal of gastroenterology.

[140]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[141]  M. Kubo,et al.  A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: The Hisayama study , 2006, International journal of cancer.

[142]  J. So,et al.  Endoscopic screening for gastric cancer. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[143]  Tomohiro Nishina,et al.  Predictive Factors of Lymph Node Metastasis in Patients With Undifferentiated Early Gastric Cancers , 2006, Journal of clinical gastroenterology.

[144]  H. Chung,et al.  Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer , 2006, The British journal of surgery.

[145]  Y. Kodera,et al.  Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry , 2006, Gastric Cancer.

[146]  F. Luca,et al.  Extended lymph node dissection without routine spleno‐pancreatectomy for treatment of gastric cancer: Low morbidity and mortality rates in a single center series of 250 patients , 2006, Journal of surgical oncology.

[147]  Jen-Hao Chen,et al.  Nodal dissection for patients with gastric cancer: a randomised controlled trial. , 2006, The Lancet. Oncology.

[148]  F. Roviello,et al.  Perforated gastric carcinoma: a report of 10 cases and review of the literature , 2006, World journal of surgical oncology.

[149]  Mario Plebani,et al.  Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[150]  H. Higashi,et al.  Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis , 2005, Cancer science.

[151]  K. Choe,et al.  Predictors of operative morbidity and mortality in gastric cancer surgery , 2005, The British journal of surgery.

[152]  E. Fontham,et al.  Long term follow up of patients treated for Helicobacter pylori infection , 2005, Gut.

[153]  Woo Jin Hyung,et al.  Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography , 2005, Cancer.

[154]  J. Yook,et al.  Clinicopathological analysis of Borrmann type IV gastric cancer. , 2005, Cancer research and treatment : official journal of Korean Cancer Association.

[155]  Shinichi Kuriyama,et al.  Cigarette smoking and the risk of gastric cancer: A pooled analysis of two prospective studies in Japan , 2004, International journal of cancer.

[156]  M. Bains,et al.  Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma , 2004, Annals of surgery.

[157]  F. Brunicardi,et al.  Schwartz's Principles of Surgery , 2004 .

[158]  S. Dexter,et al.  TNM and Japanese staging systems for gastric cancer: how do they coexist? , 2004, Gastric Cancer.

[159]  A. Nashimoto,et al.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[160]  Hong Nguyen,et al.  Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. , 2004, Archives of pathology & laboratory medicine.

[161]  D. Gouma,et al.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[162]  J. Whang‐Peng,et al.  Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer , 2004, The British journal of surgery.

[163]  H. Katoh,et al.  Evaluation of 18F-2-deoxy-2-fluoro-d-glucose Positron Emission Tomography for Gastric Cancer , 2004, World Journal of Surgery.

[164]  H. Shimada,et al.  Comparative Evaluation of Gastric Carcinoma Staging: Japanese Classification Versus New American Joint Committee on Cancer/International Union Against Cancer Classification , 2004, Annals of Surgical Oncology.

[165]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[166]  F. Graziano,et al.  The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[167]  Paolo Vineis,et al.  Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC) , 2003, International journal of cancer.

[168]  R. Haas,et al.  Helicobacter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation , 2003, Science.

[169]  H. Katai,et al.  Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach , 2003, The British journal of surgery.

[170]  T. Hirayama,et al.  Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori , 2003, Nature Genetics.

[171]  S. Tsugane,et al.  Vegetables, fruit and risk of gastric cancer in Japan: A 10‐year follow‐up of the JPHC study Cohort I , 2002, International journal of cancer.

[172]  D. Roukos,et al.  Targeting the optimal extent of lymph node dissection for gastric cancer , 2002, Journal of surgical oncology.

[173]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[174]  F. Roviello,et al.  The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients , 2002, British Journal of Cancer.

[175]  S. Kitano,et al.  Clinical Outcome of Proximal versus Total Gastrectomy for Proximal Gastric Cancer , 2002, World Journal of Surgery.

[176]  R. Jensh,et al.  Bloom & Fawcett's Concise Histology , 2002 .

[177]  Aller,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.

[178]  S. Hundahl,et al.  Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment , 2002, Annals of Surgical Oncology.

[179]  M. E. Ryan,et al.  Diagnostic laparoscopy guidelines for clinical application. , 2001, Gastrointestinal endoscopy.

[180]  K. Choe,et al.  Influence of the number of lymph nodes examined on staging of gastric cancer , 2001, The British journal of surgery.

[181]  A. Helicobacter,et al.  Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.

[182]  S. Weeden,et al.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of MRC randomized surgical trial , 2001 .

[183]  C. Caldas,et al.  E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma , 2001, Oncogene.

[184]  H. Ono,et al.  Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer , 2001, The British journal of surgery.

[185]  S. Yoshida,et al.  Endoscopic mucosal resection for treatment of early gastric cancer , 2001, Gut.

[186]  T. Yoshimura,et al.  Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989 , 2001, British Journal of Cancer.

[187]  Y. Nakanishi,et al.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers , 2000, Gastric Cancer.

[188]  T. Saito,et al.  Significant prognostic factors in patients with early gastric cancer. , 2000, International surgery.

[189]  D. Klimstra,et al.  Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients , 2000, Annals of surgery.

[190]  D. Klimstra,et al.  Analysis of 154 actual five-year survivors of gastric cancer , 2000, Journal of Gastrointestinal Surgery.

[191]  J. Willis,et al.  Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer , 2000, Nature Genetics.

[192]  J. Everhart.  Recent developments in the epidemiology of Helicobacter pylori. , 2000, Gastroenterology clinics of North America.

[193]  J. Yokota,et al.  Familial gastric cancer: overview and guidelines for management* , 1999, Journal of medical genetics.

[194]  D. Morita,et al.  Evaluation of the new American Joint Committee on Cancer/International Union Against Cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification , 1999, Cancer.

[195]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[196]  N. Kinukawa,et al.  An early gastric carcinoma treatment strategy based on analysis of lymph node metastasis , 1999, Cancer.

[197]  D. Gouma,et al.  Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.

[198]  P. Fayers,et al.  Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial , 1999, British Journal of Cancer.

[199]  E. Furtado,et al.  Early gastric cancer: Report of 58 cases , 1998, Gastric Cancer.

[200]  J. Siewert,et al.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. , 1998, Annals of surgery.

[201]  Kylie L. Gorringe,et al.  Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. , 1998, Cancer research.

[202]  M. Blaser,et al.  The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. , 1998, Gastroenterology.

[203]  D J Schaid,et al.  Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome , 1998, Annals of Internal Medicine.

[204]  Z. Cohen,et al.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli. , 1998, American journal of human genetics.

[205]  J. Reynolds,et al.  Gastric Stump Cancer: What Is the Risk? , 1998, Digestive Diseases.

[206]  L. Ventura,et al.  [Gastric carcinoma: a histopathological study of 705 cases]. , 1998, Annali italiani di chirurgia.

[207]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[208]  S. Kim,et al.  Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer , 1998, Gastric Cancer.

[209]  P. Hermanek,et al.  Classification of regional lymph node metastasis from gastric carcinoma , 1998, Cancer.

[210]  M. Brennan,et al.  Total gastrectomy is not necessary for proximal gastric cancer. , 1998, Surgery.

[211]  L. Aaltonen,et al.  Features of gastric cancer in hereditary non‐polyposis colorectal cancer syndrome , 1997, International journal of cancer.

[212]  K. Itani,et al.  Early diagnosis of signet ring cell carcinoma of the stomach: role of the Genta stain. , 1997, Journal of clinical pathology.

[213]  G. Friedman,et al.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. , 1997, Gut.

[214]  Y. Seto,et al.  Impact of lymph node metastasis on survival with early gastric cancer , 1997, World Journal of Surgery.

[215]  J. Virtamo,et al.  Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study. , 1996, Journal of clinical pathology.

[216]  P. Davaris,et al.  Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. , 1996, The Italian journal of gastroenterology.

[217]  A. Encke,et al.  A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. , 1996, Annals of surgery.

[218]  E. Kuipers,et al.  Helicobacter pylori and atrophic gastritis: importance of the cagA status. , 1996, Journal of the National Cancer Institute.

[219]  M. Inoue,et al.  Protective factor against progression from atrophic gastritis to gastric cancer—data from a cohort study in Japan , 1996, International journal of cancer.

[220]  K. Min,et al.  Epstein-Barr virus-associated gastric adenocarcinomas among Koreans. , 1996, American journal of clinical pathology.

[221]  C. Johnson,et al.  Extended lymph node dissection (D2 resection) should now be performed routinely in the curative surgical treatment of gastric carcinoma. , 1995, Annals of the Royal College of Surgeons of England.

[222]  P. Chyou,et al.  Gastric Cancer among the Japanese in Hawaii , 1995, Japanese journal of cancer research : Gann.

[223]  H. Katai,et al.  Pancreas-preserving total gastrectomy for proximal gastric cancer , 1995, World Journal of Surgery.

[224]  J. Hermans,et al.  Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients , 1995, The Lancet.

[225]  K. Sugimachi,et al.  Clinicopathologic study of patients with Borrmann type iv gastric carcinoma , 1995, Journal of surgical oncology.

[226]  M. Tsuneyoshi,et al.  Long term follow‐up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis , 1994, Cancer.

[227]  M. Rugge,et al.  Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1994, Gastroenterology.

[228]  M. Tada,et al.  Endoscopic and histologic diagnosis of submucosal tumors of the gastrointestinal tract using combined strip biopsy and bite biopsy. , 1994, Gastrointestinal endoscopy.

[229]  T. Nakajima,et al.  [Indication for the lymph node dissection of gastric cancer based on the pattern analysis small of lymphatic spread]. , 1994, Gan to kagaku ryoho. Cancer & chemotherapy.

[230]  A. Li,et al.  A Prospective Randomized Trial Comparing R1 Subtotal Gastrectomy with R3 Total Gastrectomy for Antral Cancer , 1994, Annals of surgery.

[231]  C. la Vecchia,et al.  Alcohol and the risk of cancers of the stomach and colon-rectum. , 1994, Digestive diseases.

[232]  J. Chmiel,et al.  Cancer of the stomach. A patient care study by the American College of Surgeons. , 1993, Annals of surgery.

[233]  S. Hecht,et al.  Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans. , 1993, Environmental health perspectives.

[234]  L. Hansson,et al.  Pernicious anemia and subsequent cancer. A population‐based cohort study , 1993, Cancer.

[235]  Y. Nakamura,et al.  Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. , 1992, Human molecular genetics.

[236]  S. Ascani,et al.  Association between histologic type of polyp and carcinoma in the stomach. , 1992, Gastrointestinal endoscopy.

[237]  C. la Vecchia,et al.  Family history and the risk of stomach and colorectal cancer , 1992, Cancer.

[238]  T. Muto,et al.  Lymph node metastasis from early gastric cancer: endoscopic resection of tumour , 1992, The British journal of surgery.

[239]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[240]  M. Rothmund,et al.  Lymph node counts in the upper abdomen: Anatomical basis for lymphadenectomy in gastric cancer , 1991, The British journal of surgery.

[241]  J. Vandenbroucke,et al.  Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. , 1990, Cancer research.

[242]  L. Sobin,et al.  Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[243]  F. Pardo‐Mindán,et al.  Risk of cancer in patients with gastric dysplasia follow‐up study of 67 patients , 1990, Cancer.

[244]  M. Sowa,et al.  Surgical approach to early gastric cancer with lymph node metastasis , 1989, World Journal of Surgery.

[245]  T. Nakajima,et al.  Surgery and adjuvant chemotherapy for gastric cancer. , 1989, Hepato-gastroenterology.

[246]  D. Morgan,et al.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. , 1988, Journal of medical microbiology.

[247]  D. Dent,et al.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma , 1988, The British journal of surgery.

[248]  Keiichi Maruyama,et al.  Progress in gastric cancer surgery in Japan and its limits of radicality , 1987, World Journal of Surgery.

[249]  A. Iwashita,et al.  Squamous cell carcinoma of the stomach: report of three cases. , 1986, The American journal of gastroenterology.

[250]  A. Iwashita,et al.  Adenosquamous carcinoma of the stomach. A clinicopathologic analysis of 28 cases , 1986, Cancer.

[251]  B. Gazzard,et al.  Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. , 1985, Gut.

[252]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[253]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.

[254]  D. Graham,et al.  Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. , 1982, Gastroenterology.

[255]  K. Sugimachi,et al.  Evaluation of extensive lymph node dissection for carcinoma of the stomach , 1981, World Journal of Surgery.

[256]  R Menguy,et al.  Diagnosis and management of upper gastrointestinal bleeding. , 1976, Southern medical journal.

[257]  A. Lilienfeld,et al.  MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1976, The Lancet.

[258]  M. Tatematsu,et al.  Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. , 1975, Journal of the National Cancer Institute.

[259]  G. Stemmermann,et al.  Pathology of gastric carcinoma in Japanese populations: comparisons between Miyagi prefecture, Japan, and Hawaii. , 1973, Journal of the National Cancer Institute.

[260]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.

[261]  R. Winkelmann,et al.  ACANTHOSIS NIGRICANS: A STUDY OF 90 CASES , 1968, Medicine.

[262]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[263]  J. Correia,et al.  Histochemistry of the gastric mucosa 1 , 1963, Gut.

[264]  L. Simon,et al.  Cancer of the stomach. , 1951, Connecticut state medical journal.

[265]  K. Monahan,et al.  Diagnosis and Management of Hereditary Gastric Cancer. , 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[266]  Young-Woo Kim,et al.  Multicenter Prospective Comparative Study of Robotic Versus Laparoscopic Gastrectomy for Gastric Adenocarcinoma. , 2016, Annals of surgery.

[267]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[268]  Dong Joon Shin,et al.  The learning curve associated with laparoscopic total gastrectomy , 2014, Gastric Cancer.

[269]  A. Kiss,et al.  Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy , 2014, Annals of Surgical Oncology.

[270]  H. Shimada,et al.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association , 2013, Gastric Cancer.

[271]  T. Nevalainen,et al.  Pekka Laurén and histological classification of gastric carcinoma , 2013, Gut.

[272]  Sang-Hoon Ahn,et al.  Laparoscopic double-tract proximal gastrectomy for proximal early gastric cancer , 2013, Gastric Cancer.

[273]  PhD Motohiro Hirao MD,et al.  Comparison of Billroth I and Roux-en-Y Reconstruction after Distal Gastrectomy for Gastric Cancer: One-year Postoperative Effects Assessed by a Multi-institutional RCT , 2012, Annals of Surgical Oncology.

[274]  F. Roviello,et al.  Gastric linitis plastica: which role for surgical resection? , 2011, Gastric Cancer.

[275]  Japanese Gastric Cancer Association.  Japanese gastric cancer treatment guidelines 2010 (ver. 3) , 2011, Gastric Cancer.

[276]  The International Consortium for Outcome Research in H Cancer.  The general rules for the gastric cancer study in surgery and pathology , 2006, The Japanese journal of surgery.

[277]  Tanaki Kajitani M. D..  The general rules for the gastric cancer study in surgery and pathology , 2006, The Japanese journal of surgery.

[278]  W. Hyung,et al.  Early gastric carcinoma with signet ring cell histology , 2002, Cancer.

[279]  R. P. Blankfield,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[280]  S. Markowitz,et al.  E‐cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer , 1999, Human mutation.

[281]  M. Huguier,et al.  [Extended lymph-node dissection for gastric cancer]. , 1999, Chirurgie; memoires de l'Academie de chirurgie.

[282]  S. Kono,et al.  Diet/nutrition and stomach cancer in Japan , 1997, International journal of cancer.

[283]  P. Cocco,et al.  Occupational risk factors for gastric cancer: an overview. , 1996, Epidemiologic reviews.

[284]  T. Kubota,et al.  Spleen- and pancreas-preserving total gastrectomy with superextended lymphadenectomy including dissection of the para-aortic lymph nodes for gastric cancer. , 1996, Journal of surgical oncology.

[285]  G. Fleuren,et al.  Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. , 1995, Journal of Clinical Oncology.

[286]  胃癌研究会.  Japanese classification of gastric carcinoma , 1995 .

[287]  M. Tsuneyoshi,et al.  Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. , 1994, Cancer.

[288]  H. Bartsch,et al.  DNA adducts of nitrosamines. , 1994, IARC scientific publications.

[289]  H. Stützer,et al.  Lymph node staging in 872 patients with carcinoma of the stomach and the presumed benefit of lymphadenectomy. German Stomach Cancer TNM Study Group. , 1994, Journal of the American College of Surgeons.

[290]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[291]  L. Sobin,et al.  Histological typing of gastric and oesophageal tumours , 1977 .

[292]  Ali Ms.  Letter: Geriatrics is medicine. , 1974, Lancet.

[293]  C. McConkey,et al.  Cancer of the stomach. , 1989 .

[294]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[295]  W J Macdonald,et al.  GASTRIC CARCINOMA. , 1912, Canadian Medical Association journal.